Written by
Phil Grainger
Mustafa Hassan, PhD
Share article:
MAUI Imaging has emerged from “stealth” mode to unveil its ultrasound-based Computed Echo Tomography (CET) K3900 system and announce a $4 million contract with the U.S. Department of Defense (DoD).
The CET system, which received FDA clearance in October 2023, is being implemented in a US Army Medical Research and Development Command-enabled program at the University of Maryland Shock Trauma Center in Baltimore through the Combat Casualty Care Research Program. The program aims to demonstrate that MAUI’s system can improve time to care in trauma patients, particularly in austere environments such as in the field, naval vessels, and evacuation aircraft.
Why we are covering this topic
- One of the main limitations of traditional ultrasound is its inability to visualise anatomy through certain barriers, notably the skull.
- MAUI’s CET system claims to overcome this limitation through a concave probe that fires pulses into tissue from multiple angles, allowing it to see through and around barriers.
Why it matters
- MAUI’s ultrasound technology certainly appears to be novel, and its credibility is bolstered by its FDA clearance and the DoD contract.
- However, unique technology alone is not enough to guarantee success. There are further challenges for MAUI if it is to achieve wider commercialisation.
Read the full insight with a Signify Premium Insights - Medical Imaging subscription
